Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen versus parecoxib/celecoxib for post-caesarean pain
ACTRN12618000287235Phase 4Not yet recruiting
- Sponsor
- Dr Gareth Ansell
- Start
- May 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ibuprofen, parecoxib and celecoxib in postoperative pain (2 arms), sponsored by Dr Gareth Ansell. Primary endpoint: 24-hour area under the curve pain score. Planned start May 2018; status: not yet recruiting.
02
Drugs
ibuprofenparecoxibcelecoxib
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12618000287235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000287235.